Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAART-treated”

Showing 20 of 0 results

Not applicableStudy completedNCT00001129
What this trial is testing

Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,248
Large-scale testing (Phase 3)Ended earlyNCT00296972
What this trial is testing

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Who this might be right for
Chronic Hepatitis CHIV Infections
University Health Network, Toronto 100
Not applicableStudy completedNCT00867854
What this trial is testing

Treatment De-Intensification and Residual HIV-1 in Youth

Who this might be right for
HIV-1HIV Infections
University of North Carolina, Chapel Hill 34
Not applicableStudy completedNCT00918840
What this trial is testing

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

Who this might be right for
HIV Infection
Genetic Immunity 16
Not applicableStudy completedNCT00050089
What this trial is testing

CSP #512 - Options in Management With Anti-Retrovirals

Who this might be right for
AIDSHIV Infections
US Department of Veterans Affairs 368
Not applicableWithdrawnNCT00006578
What this trial is testing

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00811954
What this trial is testing

Comparative Study of Three NNRTI-Sparing HAART Regimens

Who this might be right for
HIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1,814
Post-approval studies (Phase 4)UnknownNCT00426296
What this trial is testing

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Who this might be right for
HIV InfectionsLipodystrophy
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Testing effectiveness (Phase 2)Study completedNCT00270205
What this trial is testing

Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)Study completedNCT00221754
What this trial is testing

Pravastatin and Protease Inhibitors in HIV-infected Patients

Who this might be right for
HIV InfectionHypercholesterolemia
University Hospital, Bordeaux 21
Large-scale testing (Phase 3)Study completedNCT00158405
What this trial is testing

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 840
Post-approval studies (Phase 4)Study completedNCT00379405
What this trial is testing

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 30
Not applicableStudy completedNCT01539005
What this trial is testing

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Who this might be right for
Tuberculosis
Centre for the AIDS Programme of Research in South Africa 402
Not applicableEnded earlyNCT00428116
What this trial is testing

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Who this might be right for
HIV Infections
University of Washington 140
Post-approval studies (Phase 4)Study completedNCT00001967
What this trial is testing

Intermittent Versus Continuous Medication in the Treatment of HIV

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 123
Post-approval studies (Phase 4)UnknownNCT00740064
What this trial is testing

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Who this might be right for
HIV Infections
Denver Infectious Disease Consultants, PLLC 30
Not applicableStudy completedNCT00188851
What this trial is testing

Structured Treatment Interruption for HIV Patients With Virologic Failure

Who this might be right for
HIV
University Health Network, Toronto 196
Not applicableUnknownNCT01705873
What this trial is testing

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Who this might be right for
HIVHypercholesterolemiaDyslipidemia
Helios Salud 300
Testing effectiveness (Phase 2)Study completedNCT00194545
What this trial is testing

Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children

Who this might be right for
HIV Infections
University of Washington 100
Not applicableStudy completedNCT02440256
What this trial is testing

Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial

Who this might be right for
Opioid Use DisorderHIV
Simon Fraser University 49
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation